Home

News

Ivax International BV v Glaxo Group Ltd [2009] IEHC 27726 June 2009Michael Tappin QC and James Whyte appeared for the successful claimant in this trial in the High Court of Ireland. The trial, which lasted six weeks, concerned the validity of the Irish patent covering Glaxo’s Seretide® inhaler product. Both Michael and James have now appeared in two patent trials in the High Court of Ireland: […]
Ivax International BV v Glaxo Group Ltd [2009] IEHC 27726 June 2009Michael Tappin QC and James Whyte appeared for the successful claimant in this trial in the High Court of Ireland. The trial, which lasted six weeks, concerned the validity of the Irish patent covering Glaxo’s Seretide® inhaler product. Both Michael and James have now appeared in two patent trials in the High Court of Ireland: […]
Daniel Alexander to sit as an Appointed Person9 April 2009In April 2009, Daniel Alexander QC was appointed by the Lord Chancellor to sit as an Appointed Person under the Trade Marks Act 1994. The Appointed Person hears appeals from decisions of the Comptroller in trade mark cases.
Napp Pharmaceutical Holdings Ltd v Ratiopharm GmbH & Sandoz Ltd [2009] EWCA Civ 2521 April 2009In March 2009 Michael Tappin appeared as junior counsel for Napp at the first instance hearing and as lead counsel in the Court of Appeal. Mark Chacksfield acted for Sandoz. The patent in suit was for a controlled release formulation of an analgesic called Oxycodone, a drug that had commonly known for many years. Napp […]
Napp v Ratiopharm & Sandoz Ltd [2009] EWCA Civ 2521 April 2009In March 2009 Michael Tappin appeared as junior counsel for Napp at the first instance hearing and as lead counsel in the Court of Appeal. Mark Chacksfield acted for Sandoz. The patent in suit was for a controlled release formulation of an analgesic called Oxycodone, a drug that had commonly known for many years. Napp […]
Michael Tappin Appointed Queen’s Counsel31 March 20098 New Square is pleased to announce that Michael Tappin was appointed as Queen’s Counsel in a ceremony at the Palace of Westminster on the 30th March 2009. Michael has extensive experience in all areas of intellectual property with a particular emphasis on patents and trade marks and in 2008 won the IP Junior of […]
MMI Research Limited v Cellxion Limited and Others [2009] EWHC 418 (Pat)11 March 2009Martin Howe QC and Henry Ward appeared on behalf of the Claimants in this patent infringement action heard in January 2009. The patent in suit was entitled “Method for identifying a mobile phone user or for eavesdropping on outgoing calls”. The Claimant sued the Defendants for patent infringement in relation to a product called a […]
MMI Research Limited v Cellxion Limited and Others [2009] EWHC 418 (Pat)11 March 2009Martin Howe QC and Henry Ward appeared on behalf of the Claimants in this patent infringement action heard in January 2009. The patent in suit was entitled "Method for identifying a mobile phone user or for eavesdropping on outgoing calls". The Claimant sued the Defendants for patent infringement in relation to a product called a […]
Novartis AG v Dexcel-Pharma Ltd [2009] EWHC 3363 March 2009In Feburary 2009 Novartis AG brought a claim against Dexcel-Pharma Ltd for infringement of its patent for isolated cyclosporins, a naturally occurring peptide produced by fungi which produces immunosuppression that is useful in recipients of organ transplants. Dexcel-Pharma had not yet marketed its product, Deximune, in the UK. The validity of the patent had already […]
Novartis AG v Dexcel-Pharma Ltd [2009] EWHC 3363 March 2009In Feburary 2009 Novartis AG brought a claim against Dexcel-Pharma Ltd for infringement of its patent for isolated cyclosporins, a naturally occurring peptide produced by fungi which produces immunosuppression that is useful in recipients of organ transplants. Dexcel-Pharma had not yet marketed its product, Deximune, in the UK. The validity of the patent had already […]